CNX-1351
CAS No. 1276105-89-5
CNX-1351 ( CNX1351; CNX 1351; CNX-1351 )
Catalog No. M17234 CAS No. 1276105-89-5
CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 87 | In Stock |
|
10MG | 140 | In Stock |
|
25MG | 266 | In Stock |
|
50MG | 492 | In Stock |
|
100MG | 710 | In Stock |
|
500MG | 1467 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCNX-1351
-
NoteResearch use only, not for human use.
-
Brief DescriptionCNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
-
DescriptionCNX-1351 is a selective covalent Inhibitor of PI3Kα. In an end point assay, CNX-1351 potently inhibited PI3Kα and was 20400 times less potent against β, γ, and δ. CNX-1351 inhibit PI3Kα signaling in cells and shows prolonged inhibition consistent with a covalent mechanism of Action. CNX-1351 inhibits growth of cells dependent on PI3Kα. CNX-1351 also inhibits PI3Kα signaling in vivo and bonds to p110α.
-
SynonymsCNX1351; CNX 1351; CNX-1351
-
PathwayOthers
-
TargetOther Targets
-
RecptorPI3Kα
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1276105-89-5
-
Formula Weight573.71
-
Molecular FormulaC30H35N7O3S
-
Purity98%
-
SolubilityDMSO : ≥ 21.8 mg/mL. 38.00 mM
-
SMILESC1CN(CCN1C(=O)CCC(=O)C=C(C)C)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
-
Chemical Name1-(4-((2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-6-methylhept-5-ene-1,4-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nacht M, et al. J Med Chem. 2013 Feb 14;56(3):712-21.
molnova catalog
related products
-
Tenilsetam
Tenilsetam is an endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment.
-
Cinaciguat
Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.
-
4-Bromo-2-(2,6-dioxo...
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione is a chemical compound.